"The
Report Liver Cirrhosis - Pipeline Review, H1 2017 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Summary
Global
Markets Direct's latest Pharmaceutical and Healthcare disease
pipeline guide Liver Cirrhosis - Pipeline Review, H1 2017, provides
an overview of the Liver Cirrhosis (Gastrointestinal) pipeline
landscape.
Cirrhosis
is scarring of the liver caused by many forms of liver diseases and
conditions, such as hepatitis and chronic alcohol abuse. The scar
tissue damages the normal structure of the liver which affects the
normal flow of blood through the liver. Symptoms include loss of
appetite, itchy skin, weight loss, tiredness and weakness and nausea.
Treatment includes liver transplant surgery.
View
Report @ http://www.marketresearchreports.biz/analysis/1038195
Report
Highlights
Global
Markets Direct's Pharmaceutical and Healthcare latest pipeline guide
Liver Cirrhosis - Pipeline Review, H1 2017, provides comprehensive
information on the therapeutics under development for Liver Cirrhosis
(Gastrointestinal), complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type. The guide covers the descriptive pharmacological
action of the therapeutics, its complete research and development
history and latest news and press releases.
The
Liver Cirrhosis (Gastrointestinal) pipeline guide also reviews of key
players involved in therapeutic development for Liver Cirrhosis and
features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Phase III, Phase
II, Phase I, Preclinical and Discovery stages are 1, 6, 3, 5 and 1
respectively. Similarly, the Universities portfolio in Preclinical
and Discovery stages comprises 1 and 1 molecules, respectively.
Liver
Cirrhosis (Gastrointestinal) pipeline guide helps in identifying and
tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage. The guide is built
using data and information sourced from Global Markets Directs
proprietary databases, company/university websites, clinical trial
registries, conferences, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources. Additionally, various dynamic
tracking processes ensure that the most recent developments are
captured on a real time basis.
Get
Sample Copy Of This Report @
Scope
-
The pipeline guide provides a snapshot of the global therapeutic
landscape of Liver Cirrhosis (Gastrointestinal).
-
The pipeline guide reviews pipeline therapeutics for Liver Cirrhosis
(Gastrointestinal) by companies and universities/research institutes
based on information derived from company and industry-specific
sources.
-
The pipeline guide covers pipeline products based on several stages
of development ranging from pre-registration till discovery and
undisclosed stages.
-
The pipeline guide features descriptive drug profiles for the
pipeline products which comprise, product description, descriptive
licensing and collaboration details, R&D brief, MoA & other
developmental activities.
-
The pipeline guide reviews key companies involved in Liver Cirrhosis
(Gastrointestinal) therapeutics and enlists all their major and minor
projects.
-
The pipeline guide evaluates Liver Cirrhosis (Gastrointestinal)
therapeutics based on mechanism of action (MoA), drug target, route
of administration (RoA) and molecule type.
-
The pipeline guide encapsulates all the dormant and discontinued
pipeline projects.
-
The pipeline guide reviews latest news related to pipeline
therapeutics for Liver Cirrhosis (Gastrointestinal)
Reasons
to buy
-
Procure strategically important competitor information, analysis, and
insights to formulate effective R&D strategies.
-
Recognize emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive
advantage.
-
Find and recognize significant and varied types of therapeutics under
development for Liver Cirrhosis (Gastrointestinal).
-
Classify potential new clients or partners in the target demographic.
-
Develop tactical initiatives by understanding the focus areas of
leading companies.
-
Plan mergers and acquisitions meritoriously by identifying key
players and its most promising pipeline therapeutics.
-
Formulate corrective measures for pipeline projects by understanding
Liver Cirrhosis (Gastrointestinal) pipeline depth and focus of
Indication therapeutics.
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope.
-
Adjust the therapeutic portfolio by recognizing discontinued projects
and understand from the know-how what drove them from pipeline.
Table
of Contents
List
of Tables
List
of Figures
Introduction
Global
Markets Direct Report Coverage
Liver
Cirrhosis - Overview
Liver
Cirrhosis - Therapeutics Development
Pipeline
Overview
Pipeline
by Companies
Pipeline
by Universities/Institutes
Products
under Development by Companies
Products
under Development by Universities/Institutes
Liver
Cirrhosis - Therapeutics Assessment
Assessment
by Target
Assessment
by Mechanism of Action
Assessment
by Route of Administration
Assessment
by Molecule Type
Liver
Cirrhosis - Companies Involved in Therapeutics Development
Conatus
Pharmaceuticals Inc
Galectin
Therapeutics Inc
Gilead
Sciences Inc
Human
Stem Cells Institute
International
Stem Cell Corp
Ocera
Therapeutics Inc
Pharmicell
Co Ltd
S-Evans
Biosciences Inc
Stelic
Institute & Co Inc
Stempeutics
Research Pvt Ltd
VESSL
Therapeutics Ltd
Liver
Cirrhosis - Drug Profiles
BCD-800
- Drug Profile
Product
Description
Mechanism
Of Action
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment